RDUS: Radius Recycling, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 365.38
Enterprise Value ($M) 798.08
Book Value ($M) 582.91
Book Value / Share 20.85
Price / Book 0.63
NCAV ($M) -339.62
NCAV / Share -12.15
Price / NCAV -1.08

Profitability (mra)
Return on Invested Capital (ROIC) -0.25
Return on Assets (ROA) -0.17
Return on Equity (ROE) -0.32

Liquidity (mrq)
Quick Ratio 0.97
Current Ratio 2.02

Balance Sheet (mrq) ($M)
Current Assets 588.26
Assets 1,510.79
Liabilities 927.89
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2,738.69
Operating Income -85.23
Net Income -266.41
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -53.41
Cash from Investing -78.64
Cash from Financing 131.47

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
9 days ago 13G/A Ameriprise Financial Inc
02-07 13G/A BlackRock, Inc.
11-12 13G/A Vanguard Group Inc 5.64 0.00
10-31 13G/A Dimensional Fund Advisors Lp 6.60 -18.92

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-21 39,863 252,856 15.77
2025-02-20 47,397 261,294 18.14
2025-02-19 46,237 207,579 22.27
2025-02-18 36,044 185,313 19.45

(click for more detail)

Similar Companies
QNCX – Quince Therapeutics, Inc. QURE – uniQure N.V.
RARE – Ultragenyx Pharmaceutical Inc. REGN – Regeneron Pharmaceuticals, Inc.
REPL – Replimune Group, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Radius Health